Clinical Trial Update: An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating early vs late use of vedolizumab in ulcerative colitis (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Geert D'Haens | Conditions: Colitis, Ulcerative | Phase 4 | Status: COMPLETED